ETON insider trading
Eton Pharmaceuticals, Inc.
In the past 36 days, 1 insider sold $229K.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
David Krempa Chief Business Officer |
$229K 4,166 sh @ $55.07 |
−8.8% | Not pre-scheduled | Oct 6, 2026 Filed Oct 6, 2026 |